Chemotherapy-Induced Tumour Lysis Syndrome in Gastric Adenocarcinoma with Diffuse Liver Metastases: A Case Report
- 1 Department of Medical Oncology, Medical Faculty, Van Yuzuncu Yil University, Van, Turkey
- 2 Department of Pathology, Medical Faculty, Van Yuzuncu Yil University, Van, Turkey
- 3 Department of Medical Oncology, Medical Faculty, Van Yuzuncu Yil University, Van, Turkey
- 4 Department of Medical Oncology, Medical Faculty, Istanbul Yeni Yuzyil University, Istanbul, Turkey
Abstract
Tumour Lysis Syndrome (TLS) is an important oncological emergency case which is often found together with haematological malignities and, much less often, with solid tumours. While TLS seen in solid tumour cases usually develops following a cytotoxic chemotherapy and its prognosis is poor. We present the case of a 60-year-old man with gastric adenocarcinoma with diffuse liver metastases (image shows diffuse liver metastatic lesions) and high serum LDH levels, who developed TLS after systemic chemotherapy. With urgent and proper supportive treatment (intravenous intensive hydration, sodium bicarbonate, di uretic, calcium gluconate, allopurinol and haemodialysis), an impressive re cov ery from TLS was achieved in the patient with an advanced stage gastric can cer. The purpose of this report is to emphasize that although the present case was a rare, high physician attention is required because significant morbidity or mortality may occur when the syndrome is not duly considered during the pre-cytotoxic evaluation of the patient, when preventive measures are not taken, or if the appropriate treatment is not applied immediately once the syndrome appears, especially in patients who have high tumour burden solid cancer.
- Cairo, M.S. and Bishop, M. (2004) Tumour Lysis Syndrome: New Therapeutic Strategies and Classification. British Journal of Haematology, 127, 3-11. https://doi.org/10.1111/j.1365-2141.2004.05094.x
- Davidson, M.B., Thakkar, S., Hix, J.K., et al. (2004) Pathophysiology, Clinical Consequences, and Treatment of Tumour Lysis Syndrome. American Journal of Medicine, 116, 546-554. https://doi.org/10.1016/j.amjmed.2003.09.045
- Kekre, N., Djordjevic, B. and Touchie, C. (2012) Spontaneous Tumour Lysis Syndrome. CMAJ, 184, 913-916. https://doi.org/10.1503/cmaj.111251
- Hande, K.R. and Garrow, G.C. (1993) Acute Tumour Lysis Syndrome in Patients with High-Grade Non-Hodgkin’s Lymphoma. American Journal of Medicine, 94, 133-139. https://doi.org/10.1016/0002-9343(93)90174-N
- Gemici, C. (2006) Tumour Lysis Syndrome in Solid Tumours. Clinical Oncology, 18, 773-780. https://doi.org/10.1016/j.clon.2006.09.005
- Coiffier, B., Altman, A., Pui, C.H., et al. (2008) Guidelines for the Management of Pediatric and Adult Tumour Lysis Syndrome: An Evidencebased Review. Journal of Clinical Oncology, 26, 2767-2778. https://doi.org/10.1200/JCO.2007.15.0177
- Arrambide, K. and Toto, R.D. (1993) Tumour Lysis Syndrome. Seminars in Nephrology, 13, 273-280.
- Kattan, J., Culine, S., Tavakoli-Razavi, T., et al. (1994) Acute Tumour Lysis Syndrome in Poor-Risk Germ Cell Tumours: Does It Exist? Support Care Cancer, 2, 128-131. https://doi.org/10.1007/BF00572095
- Barton, J.C. (1989) Tumor Lysis Syndrome in Nonhematopoietic Neoplasms. Cancer, 64, 738-740. https://doi.org/10.1002/1097-0142(19890801)64:3 3.0.CO;2-Z
- Garnick, M.B. and Mayer, R.J. (1978) Acute Renal Failure Associated with Neoplastic Disease and Its Treatment. Seminars in Oncology, 5, 155-165.